Resistant and relapsing Lyme disease, Babesiosis, Bartonellosis as well as other persistent intracellular pathogens are often causing relapses in our sickest tick-borne patient population.

 from Dr Horowitz

Dr Kenneth Leigner just published a study of three patients on disulfiram for the treatment of Lyme disease based on the work of Dr Kim Lewis. Thank you Ken for sharing your work. Resistant and relapsing Lyme disease, Babesiosis, Bartonellosis as well as other persistent intracellular pathogens are often causing relapses in our sickest tick-borne patient population. 



https://res.mdpi.com/antibiotics/antibiotics-08-00072/article_deploy/antibiotics-08-00072.pdf?filename&attachment=1&fbclid=IwAR2F_koQxvZCzgbXlOkLzgC5AeVZaVZNaRcKL8_P9AIQMXseFylyM4TuZPc